The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Cytoplasmic destruction of p53 by the endoplasmic reticulum‐resident ubiquitin ligase ‘Synoviolin’
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
Brand, A. H., & Perrimon, N. (1993) · Development · doi:10.1242/dev.118.2.401 · Cited by 9,612
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“To address this question, we applied genotoxic stress as a stimulus for p53 activation (Kastan et al, 1991; Vogelstein et al, 2000).”
MethodMdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 14×
“The amount of p53 by synoviolin ablation was less than that byMDM2 ablation, but equivalent to that by Cop1 ablation.”
BackgroundInfluentialParticipation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×
“As a positive control, p53 was ubiquitinated by MDM2 in an in vivo ubiquitination assay (Figure 5C) (Haupt et al, 1997; Kubbutat et al, 1997).”
BackgroundHopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
p53 ubiquitination: Mdm2 and beyond
Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924
From acute ER stress to physiological roles of the Unfolded Protein Response
Wu, J., & Kaufman, R. J. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401840 · Cited by 868
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 722
The ubiquitin ligase COP1 is a critical negative regulator of p53
Dornan, D., Wertz, I., Shimizu, H., Arnott, D., Frantz, G. D., Dowd, P., O' Rourke, K., Koeppen, H., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02514 · Cited by 704
Absence of HeLa Cell Contamination in 169 Cell Lines Derived From Human Tumors2
Fogh, J., Wright, W. C., & Loveless, J. D. (1977) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/58.2.209 · Cited by 663
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Moll, U. M., Riou, G., & Levine, A. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7262 · Cited by 575
Drosophila p53 Binds a Damage Response Element at the reaper Locus
Brodsky, M. H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G. M., & Abrams, J. M. (2000) · Cell · doi:10.1016/s0092-8674(00)80627-3 · Cited by 473
Harrison, D. A., Binari, R., Nahreini, T. S., Gilman, M., & Perrimon, N. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07285.x · Cited by 469
Swanson, R., Locher, M., & Hochstrasser, M. (2001) · Genes & Development · doi:10.1101/gad.933301 · Cited by 455
Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control
Vashist, S., & Ng, D. T. W. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200309132 · Cited by 449
Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53
Ollmann, M., Young, L. M., Di Como, C. J., Karim, F., Belvin, M., Robertson, S., Whittaker, K., Demsky, M., Fisher, W. W., Buchman, A., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80626-1 · Cited by 412
Kikkert, M., Doolman, R., Dai, M., Avner, R., Hassink, G., van Voorden, S., Thanedar, S., Roitelman, J., Chau, V., & Wiertz, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307453200 · Cited by 384 · cited 1×
“In the present study, we demonstrated that Synoviolin participates in genotoxic stress-mediated p53 signaling, and its to participation in the ER stress-induced apoptosis is also well known (Bordallo et al, 1998; Kaneko et al, 2002; Kikkert et al, 2004; Yagishita et al, 2005).”
BackgroundSomatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium
Firestein, G. S., Echeverri, F., Yeo, M., Zvaifler, N. J., & Green, D. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10895 · Cited by 377
Bordallo, J., Plemper, R. K., Finger, A., & Wolf, D. H. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.1.209 · Cited by 374
Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage.
Smith, M. L., Chen, I. T., Zhan, Q., O'Connor, P. M., & Fornace, A. J. (1995) · PubMed · Cited by 364
Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A., & Rotter, V (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.12.6565 · Cited by 356
Nikolaev, A. Y., Li, M., Puskas, N., Qin, J., & Gu, W. (2003) · Cell · doi:10.1016/s0092-8674(02)01255-2 · Cited by 356
Two established in vitro cell lines from human mesenchymal tumours
Ponten, J., & Saksela, E. (1967) · International Journal of Cancer · doi:10.1002/ijc.2910020505 · Cited by 345
The p53 response to DNA damage
Meek, D. W. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.027 · Cited by 329
Cytoplasmic Sequestration of Wild-Type p53 Protein Impairs the G 1 Checkpoint after DNA Damage
Moll, U. M., Ostermeyer, A. G., Haladay, R., Winkfield, B., Frazier, M., & Zambetti, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1126 · Cited by 277
Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy
Amano, T., Yamasaki, S., Yagishita, N., Tsuchimochi, K., Shin, H., Kawahara, K.-I., Aratani, S., Fujita, H., Zhang, L., Ikeda, R., et al. (2003) · Genes & Development · doi:10.1101/gad.1096603 · Cited by 270
Self-citationQu, L., Huang, S., Baltzis, D., Rivas-Estilla, A.-M., Pluquet, O., Hatzoglou, M., Koumenis, C., Taya, Y., Yoshimura, A., & Koromilas, A. E. (2004) · Genes & Development · doi:10.1101/gad.1165804 · Cited by 245
Human HRD1 protects against ER stress‐induced apoptosis through ER‐associated degradation1
Kaneko, M., Ishiguro, M., Niinuma, Y., Uesugi, M., & Nomura, Y. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03660-8 · Cited by 217
New approaches to understanding p53 gene tumor mutation spectra
Hollstein, M., Hergenhahn, M., Yang, Q., Bartsch, H., Wang, Z.-Q., & Hainaut, P. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00162-1 · Cited by 198
Nishikawa, S.-I., Brodsky, J. L., & Nakatsukasa, K. (2005) · The Journal of Biochemistry · doi:10.1093/jb/mvi068 · Cited by 174
Gottlieb, E. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1381 · Cited by 166
Regulation of Joint Destruction and Inflammation by p53 in Collagen-Induced Arthritis
Yamanishi, Y., Boyle, D. L., Pinkoski, M. J., Mahboubi, A., Lin, T., Han, Z., Zvaifler, N. J., Green, D. R., & Firestein, G. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64356-8 · Cited by 142
A FancD2-Monoubiquitin Fusion Reveals Hidden Functions of Fanconi Anemia Core Complex in DNA Repair
Matsushita, N., Kitao, H., Ishiai, M., Nagashima, N., Hirano, S., Okawa, K., Ohta, T., Yu, D. S., McHugh, P. J., Hickson, I. D., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.018 · Cited by 142
Self-citationSomatic mutation in the tumore suppressor gene in erosive rheumatoid arthritis synovium
Firestein, G. (1997) · Medical Entomology and Zoology · Cited by 123
Pluquet, O., Qu, L., Baltzis, D., & Koromilas, A. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9392-9405.2005 · Cited by 121
Essential Role of Synoviolin in Embryogenesis
Yagishita, N., Ohneda, K., Amano, T., Yamasaki, S., Sugiura, A., Tsuchimochi, K., Shin, H., Kawahara, K.-I., Ohneda, O., Ohta, T., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410863200 · Cited by 108
Self-citationMutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue
Reme, T. X., Travaglio‐Encinoza, A., Gueydon, E., Adla, L., Jørgensen, C., & Sany, J. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00508.x · Cited by 96
Nuclear Exclusion of Wild-Type p53 in Immortalized Human Retinoblastoma Cells
Schlamp, C. L., Poulsen, G. L., Nork, T. M., & Nickells, R. W. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.20.1530 · Cited by 75
Lipid‐mediated, reversible misfolding of a sterol‐sensing domain protein
Shearer, A. G., & Hampton, R. Y. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600498 · Cited by 73
Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium
Inazuka, M., Tahira, T., Horiuchi, T., Harashima, S., Sawabe, T., Kondo, M., Miyahara, H., & Hayashi, K. (2000) · British journal of rheumatology · doi:10.1093/rheumatology/39.3.262 · Cited by 71
Structural Control of Endoplasmic Reticulum-associated Degradation
Shearer, A. G., & Hampton, R. Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307734200 · Cited by 58
Regulation of arthritis by p53: Critical role of adaptive immunity
Šimelyte, E., Rosengren, S., Boyle, D. L., Corr, M., Green, D. R., & Firestein, G. S. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21099 · Cited by 58
Ubiquitin-dependent degradation of the yeast Matα2 repressor enables a switch in developmental state
Laney, J. D., & Hochstrasser, M. (2003) · Genes & Development · doi:10.1101/gad.1115703 · Cited by 49
p53, proto-oncogene and rheumatoid arthritis
Sun, Y., & Cheung, H. S. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.31550 · Cited by 48
Identification of a Crucial Site for Synoviolin Expression
Tsuchimochi, K., Yagishita, N., Yamasaki, S., Amano, T., Kato, Y., Kawahara, K., Aratani, S., Fujita, H., Ji, F., Sugiura, A., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7344-7356.2005 · Cited by 27
Self-citation
Cited by
HECT and RING finger families of E3 ubiquitin ligases at a glance
Metzger, M. B., Hristova, V. A., & Weissman, A. M. (2012) · Journal of Cell Science · doi:10.1242/jcs.091777 · Cited by 630
ER-associated degradation: Protein quality control and beyond
Ruggiano, A., Foresti, O., & Carvalho, P. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201312042 · Cited by 607
Quality Control in the Endoplasmic Reticulum: Crosstalk between ERAD and UPR pathways
Hwang, J., & Qi, L. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.06.005 · Cited by 592
p53 post-translational modification: deregulated in tumorigenesis
Dai, C., & Gu, W. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.09.002 · Cited by 523
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
“Synoviolin, a component of the ER-associated degradation (ERAD) complex, is an E3 ubiquitin ligase that targets p53, and it is engaged in endoplasmic reticulum related degradation, an ATPdependent ubiquitin-proteasome degradation process that reduces the burden on the ER.298,299 Synoviolin sets p53 apart in the cytopl…”
Background
Metadata
- Authors
- Yamasaki, S., Yagishita, N., Sasaki, T., Nakazawa, M., Kato, Y., Yamadera, T., Bae, E., Toriyama, S., Ikeda, R., Zhang, L., Fujitani, K., Yoo, E., Tsuchimochi, K., Ohta, T., Araya, N., Fujita, H., Aratani, S., Eguchi, K., Komiya, S., Maruyama, I., Higashi, N., Sato, M., Senoo, H., Ochi, T., Yokoyama, S., Amano, T., Kim, J., Gay, S., Fukamizu, A., Nishioka, K., Tanaka, K., & Nakajima, T.
- Venue
- The EMBO Journal
- Published
- 2006-12-14
- Volume
- 26
- Issue
- 1
- Pages
- 113-122
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W1993964409
- Cited by
- 275
- References
- 50
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.